Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Perfect Brows for the Perfect Day: Why Every Bride Needs Semi-Permanent Eyebrows Business
  • Avani Institute of Design Introduces 5 Year Integrated B.Des–M.Des Dual Degree Program Education
  • Opa! Bar & Cafe : Launches Delectable New Middle-Eastern Spread! Business
  • Haresh Sippy’s Living on the Edge: A Guide to Living to the Fullest Explores Life, Uncertainty and the Pursuit of Fulfillment Lifestyle
  • The Able Leadership of Shri Narendra Modi: Acharya Pawan Tripathi (VP- Mumbai BJP) Press Release
  • Beyond Personal Massagers: Libertee’s Human Touch Driving India’s Intimacy Revolution Lifestyle
  • India’s first 15-layer calibrated plywood brand ‘Speckwud’ launched in Hyderabad by Gupta Plywood Business
  • Ashok Prasad Abhishek sponsored Asia’s biggest cruise festival Business

Vaishali Pharma Ltd Fixes Record Date for 1 to 1 Bonus Issue and 1 to 5 Stock Split

Posted on October 4, 2024 By

Mumbai (Maharashtra) [India] October 4: The board of directors of Mumbai-based Vaishali Pharma Ltd (NSE–VAISHALI) has fixed the “Record Date” as Tuesday, 15th October 2024. The Company will Split its Equity Shares, having a nominal/face value of INR 10 each (Rupees Ten only), into 5 (Five) equity shares of INR 2 each (Rupee Two only) of the Shareholders holding shares as of the Record Date, i.e., Tuesday, 15th October 2024.

Further, the Bonus Shares will be issued to the Shareholders of the Company in the ratio of 1:1, i.e., 1 (One) new fully paid-up Equity Share of ₹ 2/- (Rupees Two Only) each for every 1 (One) existing fully paid-up Equity Share of ₹ 2/- (Rupees Two Only) each held by the eligible Shareholders of the Company as on the Record Date i.e Tuesday, 15th October 2024.

Catering to semi-regulated and non-regulated markets across the world, the company had recently obtained 19 registrations across Southern Africa, West Africa, the Gulf region, Latin America and the ASEAN region. These registrations are poised to contribute around Rs 100 million to the company’s annual revenue.

Vaishali Pharma Ltd

Highlights 

  • Bonus issue is aimed at rewarding existing shareholders, enhancing liquidity, and expanding the shareholder base
  • Company had recently obtained 19 registrations across Southern Africa, West Africa, the Gulf region, Latin America etc, expected to contribute around Rs. 100 million to the company’s annual revenue
  • Mumbai-based pharma company has over 250 + formulation brands marketed in multiple countries and a robust pipeline of around 250 Dossiers.
  • Company has fixed the “Record Date” as Tuesday, 15th October, 2024
  • The Company will Split its Equity Shares of Rs 10 each into 5 equity shares of Rs 2 each.
  • The Bonus Shares will be issued to the Shareholders of the Company in a ratio of 1:1

Backed by strong product portfolio and distribution network, the Company had reported robust financial performance for Q1FY25. For the quarter ended on June 30, 2024, the Company’s sales increased by 34.70% to Rs 18.08 crore in Q1FY25 compared to Rs 13.42 crore during Q1FY24. Net Profit of the company rose 7.13% to Rs 1.70 crore as against Rs 1.59 crore during the previous quarter ended June 2023.

Commenting on the development, Mr. Atul Vasani, Chairman and Managing Director, Vaishali Pharma Ltd said, “We are proud to inform our stakeholders that the company is making significant strides in its long-term growth strategy, delivering excellent operational and financial results. Consideration of stock split and bonus shares are in line with the company’s vision to reward the shareholders and earn their long-lasting trust and confidence. This move will not only reward our existing shareholders for their continued support but also increase the company’s equity base, thereby enhancing liquidity. With a focus on growth and innovation, the company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector.”

Established in 1989, Vaishali Pharma Limited specializes in the production and marketing of a diverse range of pharmaceutical products, including APIs, formulations, surgical products, veterinary supplements, herbal items, nutraceuticals, and oncology products. Their portfolio serves both human and animal healthcare needs. The company has over 250 + formulation brands marketed in multiple countries and a robust pipeline of around 250 Dossiers. The company’s synergistic collaboration with WHO-GMP manufacturing facilities is backed by an excellent rapport with clients. Company is one of the fastest growing and most versatile company in the pharmaceutical industry. It has a strong presence in both the domestic and export markets and is currently supplying to all leading Indian and international companies.

With a vision “To be a well-recognised Indian MNC in the pharmaceuticals and healthcare industry”, the company continue to work on its mission to contribute substantially towards well-being and health of the society by providing high quality products and service.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investing in stocks involves risk, and past performance is not indicative of future results. Readers should conduct their own research or consult with a qualified financial advisor before making any investment decisions.

Business Tags:Business

Post navigation

Previous Post: Dastak, Singapore’s renowned Theatre and Film Festival, makes its Indian Debut in Vadodara
Next Post: Lal Bahadur Shastri National Memorial Trust Commemorate 120th Birth Anniversary of Lal Bahadur Shastri 

Related Posts

  • SK Finance Delivers Robust FY26 Performance; AUM Crosses Rs. 15,755 Cr, PAT Jumps to Rs. 431 Cr Business
  • A Significant Session with Designer Niti Singhal for IDT Students Business
  • PE Front Office – A software solution that can power your Alternative Investment Fund ahead Business
  • Fiberweb India Limited Reports Q1 FY27 Performance with ₹ 10.02 Cr Total Income Growth and 18.72% EBITDA Margin Business
  • Ayursetu Announces Name Change to AAYUSETU Business
  • CLEAR Water ties up with Recycle.Green on its 18th anniversary to become a Zero Waste Brand Business

Recent Posts

  • ORGATEC India 2026 Outlines a Roadmap for Growth Amid a 15% Rise in Commercial Real Estate Investments
  • From Needle and Thread to Virar’s Spotlight: DhaagaDhari’s Handmade Brand Wins Hearts at Virar Flea Market
  • Medvyn Builds a National Platform for India’s Doctors, Hospitals and Healthcare Talent, Led by Founder Hardik Gajjar
  • Meeta Kotadia brings international recognition to India, winning the 2nd Runner-Up title along with two prestigious special awards at the global beauty pageant.
  • The CHRO’s Real Job as per Tutul Consulting Goes Beyond Keeping People Happy and More Toward Shaping Enterprise Mindset

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • ‘The Big Daddy House’ suspense thriller film released at MX player Entertainment
  • Zoya by Tata Unveils Exquisite Jewelry Collections at Palladium Ahmedabad, Elevating the Essence of Femininity and Elegance Business
  • Indore Child Psychologist Dr. Vini Jhariya Addresses the ‘Intelligent but Struggling’ Gap in Student Learning Lifestyle
  • Limelight Lab Grown Diamonds crosses 100 stores milestone this Dussehra: targets 200 in 2027 Business
  • A National Best Selling Author, Releases His Next Book “Unhooked & Unbooked” Lifestyle
  • Avatar 2 release date, cast, trailer and all you need to know about The Way of Water Entertainment
  • Guntur-based Dr. Rao’s Hospital offers the latest and result-oriented Minimally Invasive Neurosurgery procedures Business
  • Hafele’s ASKO and Falmec Luxury Appliances Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme